Medtronic (NYSE:MDT) today released clinical data from a study of its VenaSeal closure system, claiming consistent long-term durability and improved quality of life in patients with venous reflux disease treated with the system The VenaSeal system from the Fridley, Minn.-based medical giant uses a proprietary medical adhesive to close superficial veins in lower extremities in patients […]
Clinical Trials
Recent TAVR approvals prompt changes to Direct Flow’s Salus trial
Direct Flow Medical said today that recent FDA approvals for transcatheter aortic valve replacements prompted it to make changes to the Salus trial of its own TAVR entry. Salus, originally aimed at enrolling 1,262 patients, is now expected to enroll a little more than half that number, 648 subjects, the company said. Santa Rosa, Calif.-based […]
Medtronic touts Endurant stent graft data, lowered mortality
Medtronic (NYSE:MDT) today released data from the Engage global registry study of its Endurant abdominal aortic aneurysm stent graft, touting lowered mortality and rupture rates compared to the earlier Evar 1 trial. Data from the studies was presented at the 2016 Charing Cross Symposium in London, Fridley, Minn.-based Medtronic said. “In the comparison analysis of Engage and […]
Fourth patient converts from complete to incomplete spinal cord injury in InVivo trial
InVivo Therapeutics (NSDQ:NVIV) said today 4th patient in the Inspire study of its Neuro-Spinal Scaffold has improved from a complete AIS A spinal cord injury to an incomplete AIS B spinal cord injury. The Cambridge, Mass.-based company’s neuro-spinal scaffold is surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. […]
Medtronic touts multi-trial In.Pact Admiral data
Medtronic (NYSE:MDT) today released a bevy of new data from clinical studies of its In.Pact Admiral drug coated balloon designed for treating peripheral artery disease. The Fridley, Minn.-based released data from 3 different studies of its In.Pact Admiral DCB at the 2016 Charing Cross Symposium meeting in London, including 1-year results from a chronic total occlusion imaging […]
AJRR inks deal with medical societies for collaborative joint registry
The American Joint Replacement Registry said today it is collaborating with the American Orthopaedic Association and the American Association of Hip and Knee Surgeons to create a joint registry through the AJRR’s Orthopaedic Quality Resource Center. The AJRR said its Orthopaedic Quality Resource Center was approved as a Qualified Clinical Data Registry for the Centers […]
Biotronik touts long-term Linox ICD lead data
Biotronik today released long-term data from registry studies of its Linox and Linoxsmart implantable cardioverter defibrillator leads, touting the survival probabilities of over 95% at 4 and 5 years. The company said its Galaxy and Celestial registry studies include data from a total of 3,933 Linox ICD leads implanted in 3,840 patients across 146 U.S. study […]
Gore touts 1st implant of Synecor in CQI trial
W.L. Gore & Associates said today its Synecor biomaterial designed for hernia repair was used in the 1st procedure of its clinical quality improvement project. The robotically assisted surgical procedure was performed at the Our Lady of the Lake hospital in Baton Rouge, La. by Dr. Karl LeBlanc, the Newark, Del.-based company said. “I think that […]
FDA grants IDE to NovoCure for phase II Optune trial
NovoCure (NSDQ:NVCR) said today that Radiation Therapy Oncology Group Foundation won FDA investigational device exemption to conduct a Phase II pilot test of NovoCure’s Optune in conjunction with bevacizumab to treat bevacizumab-refractory recurrent glioblastoma. The Optune is a mobile device that delivers low-intensity, intermediate frequency, alternating electric fields, referred to as “tumor treating fields” to inhibit […]
Si-Bone touts maintained results at 2 years in iFuse study
Si-Bone this week released 2-year results from the SIFI trial of iFuse implant system designed for sacroiliac joint fusion procedures, touting improvements in quality of life and a 28% reduction in opioid use. Results from the trial were published in The International Journal of Spine Surgery, the San Jose, Calif.-based company said. The 172-patient multi center […]
Study: Medtronic touts increased AF detection with Reveal Linq system
Medtronic (NYSE:MDT) today released 1-year results from a study of patients who experienced a cryptogenic stroke, claiming that its Reveal Linq insertable cardiac monitor was able to detect atrial fibrillation at a greater rate than previously reported in a 2014 clinical trial. Results from the real-world study were presented at the 68th American Academy of Neurology’s […]